FDA to decide by March 17 on Pfizer/Bristol blood thinner
September 26, 2012 at 17:24 PM EDT
Sept 26 (Reuters) - U.S. health regulators set a date of March 17 to decide whether to approve a closely watched blood clot preventer developed by Bristol-Myers Squibb Co and Pfizer Inc for use in patients suffering from atrial fibrillation, the companies said on Wednesday.
